The abstract submission window is now officially closed. We appreciate the high volume of interest and scholarly contributions.
Selected abstracts will come to life in person at both conferences:
The VEINS Late-Breaking Clinical Trials – Sunday, November 2, 2025
VIVA Late-Breaking Clinical Trials – Monday & Tuesday, November 3 – 4, 2025
Research will be followed by live Q&A sessions and expert panel discussions
Get a first look at innovative findings in vascular medicine
Join interactive discussions with leading experts
Keep your finger on the pulse of emerging clinical trends, live in Las Vegas!
Review Period: Completed following the August 7 deadline, with decisions communicated the week of August 25, 2025. What’s Next: If your abstract is accepted, you'll receive instructions for registration and presentation details from the program faculty manager.
Prospective late-breaking presenters should not register for the conference until after the abstract submission results are disseminated. If you are selected as a presenter, you will receive specific instructions to register from the faculty manager.
Each abstract was expected to include:
Trial name, purpose, and design (materials and methods)
Clear, original results and conclusions
Commitment that the findings had not been publicly presented prior
Submissions were evaluated on relevance to the field, methodological rigor, strength of data, and significance of endpoints.
If you have questions please contact Brita Thorne via e-mail: abstracts@viva-foundation.org
